Margaret Clagett-Dame
Affiliations: | University of Wisconsin, Madison, Madison, WI |
Area:
BiochemistryWebsite:
https://biochem.wisc.edu/faculty/clagett-dameGoogle:
"Margaret Clagett-Dame"Bio:
https://books.google.com/books?id=l_drAAAAMAAJ
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Hector Floyd DeLuca | grad student | 1985 | UW Madison | |
| Colleen E. Hayes | grad student | 1985 | UW Madison (Cell Biology Tree) | |
| (The 1,25-dihydroxyvitamin D3 receptor: partial purification from porcine intestine and production of monoclonal anti-receptor antibodies) | ||||
Children
Sign in to add trainee| Mark Marzinke | grad student | UW Madison | |
| Jason S. Chapman | grad student | 2004 | UW Madison |
| Danielle C. Knutson | grad student | 2008 | UW Madison |
| Angela W. See | grad student | 2008 | UW Madison |
| Elizabeth M. McNeill | grad student | 2009 | UW Madison (Evolution Tree) |
| Nirca J. Nieves | grad student | 2009 | UW Madison |
| Allyson L. Anding | grad student | 2011 | UW Madison |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pook C, Ahrens JM, Clagett-Dame M. (2020) Expression pattern of Nav2 in the murine CNS with development. Gene Expression Patterns : Gep. 35: 119099 |
| Plum LA, Zella J, Clagett-Dame M, et al. (2019) A New 1,25 Dihydroxy Vitamin D Analog with Strong Bone Anabolic Activity in OVX Rats with Little or No Bone Resorptive Activity. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research |
| Anding AL, Jones JD, Newton MA, et al. (2018) 4-HPR Is an Endoplasmic Reticulum Stress Aggravator and Sensitizes Breast Cancer Cells Resistant to TRAIL/Apo2L. Anticancer Research. 38: 4403-4416 |
| Ahrens JM, Jones JD, Nieves NJ, et al. (2017) Differential activity of 2-methylene-19-nor vitamin D analogs on growth factor gene expression in rhino mouse skin and comparison to all-trans retinoic acid. Plos One. 12: e0188887 |
| Pandey R, Zella JB, Zhu JG, et al. (2017) Pharmacokinetics of a New Oral Vitamin D Receptor Activator (2-Methylene-19-Nor-(20S)-1α,25-Dihydroxyvitamin D3) in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism on Hemodialysis. Drugs in R&D |
| Cavanaugh KR, Narayanasamy S, Walker JR, et al. (2016) Improved Synthesis of the C-Glucuronide/Glycoside of 4-Hydroxybenzylretinone (4-HBR). Journal of Carbohydrate Chemistry. 35: 249-260 |
| Thadhani R, Zella JB, Knutson DC, et al. (2016) 2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized Trial. American Journal of Nephrology. 45: 40-48 |
| Pandey R, Zella J, Clagett-Dame M, et al. (2016) Use of 2MD, a Novel Oral Calcitriol Analog, in Hemodialysis Patients with Secondary Hyperparathyroidism. American Journal of Nephrology. 43: 213-220 |
| Knutson DC, Mitzey AM, Talton LE, et al. (2016) Mice null for NEDD9 (HEF1) display extensive hippocampal dendritic spine loss and cognitive impairment. Brain Research. 1632: 141-55 |
| Knutson DC, Clagett-Dame M. (2015) A complex RARE is required for the majority of Nedd9 embryonic expression. Transgenic Research. 24: 123-34 |